Compare · 2 funds side by side · dividends reinvested

CURE and VOO

Not found: TQQQ

CUREDirexion×VOOVanguard×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$17,749VOO · best of the two

02 / 04

CURE and VOO, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Vanguard S&P 500 ETFLow-Cost Core · S&P 5000.03%1.07%+11.5%+11.9%+24.1%+12.2%−8.9%12.7%$1.00T1.4

Direxion Daily Healthcare Bull 3X ETFLeveraged · 3x0.94%0.76%+49.8%+82.5%+31.0%+7.8%−31.1%48.0%$200M1.6

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: CURE 2011 · VOO 2010

Head to Head

Swap sides Versus in desk

Head to Head

Direxion Daily Healthcare Bull 3X ETF · $200M$14,551

CURE

VOO

Vanguard S&P 500 ETF · $1.00T$17,749

$10,000 five years ago, dividends reinvested · they hold 9.3% in common

CUREMeasureVOO

+49.8%Year to dateJan 1 → Nov 3+11.5%

+82.5%1 yearTotal return+11.9%

+31.0%3 years · per year$10,000 became $22,495 · $19,094+24.1%

+7.8%5 years · per year$10,000 became $14,551 · $17,749+12.2%

0.94%Expense ratio$94 · $3 a year on $10k · lower is better0.03%

0.76%Trailing 12-mo yield$76 · $107 a year on $10k1.07%

−31.1%Worst dropSmaller is better−8.9%

48.0%VolatilityLower is calmer12.7%

CUREVOO Winner of the row, in its colourEach row: the bigger of the two fills its side

3–5VOO wins

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

CURE vs VOO: Top 5 Holdings

Today

CURE

9.4%in top 5

VOO

in top 528.3%

CUREStockVOO

not top 5NVDA8.4%

not top 5AAPL7.4%

not top 5MSFT5.8%

not top 5AMZN3.7%

3.5%LLYnot top 5

not top 5GOOGL3.1%

2.0%JNJnot top 5

1.6%ABBVnot top 5

1.1%MRKnot top 5

1.1%UNHnot top 5

Held in common9.3%

End-of-day Nov 3, 2026 · share of each fund

CURE vs VOO Returns, Every Period

DirexionCURE

+7.8%

5 years, per year

VOOVanguard

+12.2%

5 years, per year

CUREVOOFaded: behind in that period

3–1CURE wins

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

Leveraged vs Core: CURE vs VOO

YTD

DirexionCURE

+49.8%

VOOVanguard

+11.5%

+49.8%Year to date+11.5%

−31.1%Worst drop · 1Y−8.9%

48.0%Volatility · 1Y12.7%

0.8%Yield1.1%

$200MAssets$1.00T

3–1VOO wins

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: CURE, VOO

Today

0.03%lowest, VOO

FundExpense ratioFee$10k

VOO0.03%$3

CURE0.94%$94

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: CURE, VOO

1.07%highest, VOO

FundTrailing yieldYield$10k

VOO1.07%$107

CURE0.76%$76

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

$104most kept, VOO

VOO$107 − $3 = $104

CURE$76 − $94 = −$18

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: CURE, VOO

Today

9.3%most shared, CURE and VOO

CUREVOO

CURE—9.3%

VOO9.3%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+82.5%CURE, at 48.0% volatility

VOOWorst drop−8.9%12.7% vol

CUREWorst drop−31.1%48.0% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

VOOCURE

+11.5%Year to date+49.8%

1.1%Yield0.8%

+11.9%Past year+82.5%

0.03%Fee0.94%

2–2level

End-of-day Nov 3, 2026

Popular Pairs Near These Two

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026

VOO vs IVV

YTD

VanguardVOO

+11.5%

IVViShares

+11.6%

+11.5%Year to date+11.6%

1.1%Yield1.1%

$1.00TAssets$872B

1–0IVV wins

End-of-day Nov 3, 2026

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026